New eye injection aims to slow blindness in rare genetic disease
Disease control
Ongoing
This study tests an experimental drug called ultevursen for people with retinitis pigmentosa caused by a specific gene mutation (USH2A). The drug is injected into the eye and may help slow vision loss. The trial involves 81 participants, some of whom will receive a sham (fake) in…
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC